Clinical trials · Washington, D.C., DC
Lymphangioleiomyomatosis clinical trials in Washington, D.C.
We’re tracking 3 recruiting lymphangioleiomyomatosis studies with a site in or near Washington, D.C. — including Phase 1/Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Washington, D.C.
- NCT05676099Recruiting
TSC or LAM blood and health information registry
This study sets up a database and collection of “biosamples” (like blood or other body samples) from people with tuberous sclerosis complex (TSC) or sporadic lymphangioleiomyomatosis (LAM). The goal is to better understand how these conditions change over time and support future research.
Silver Spring, MarylandAges Any age - NCT01799538RecruitingPhase 1/Phase 2
Inhaled albuterol for lung disease LAM
This Phase 1/2 study tests whether breathing in albuterol can improve symptoms or lung function in people with lymphangioleiomyomatosis (LAM). It’s mainly about safety and early signs of benefit by targeting airflow problems.
Bethesda, MarylandAges 18–100 - NCT00001465Recruiting
Study of lymphangioleiomyomatosis (LAM) disease process
This study looks at the natural history and disease process of lymphangioleiomyomatosis (LAM), a rare lung disease that mostly affects women. It may help understand how LAM progresses and how it affects daily life, and may include exercise testing and other evaluations.
Bethesda, MarylandAges 16–100
Hear when a new Lymphangioleiomyomatosis trial opens near Washington, D.C., DC
We’ll email you when one opens near Washington, D.C., DC — at most once a week, no account needed, unsubscribe anytime.
Lymphangioleiomyomatosis trials in other cities
Where these studies are running near Washington, D.C.
Institutions with a site for the recruiting lymphangioleiomyomatosis studies listed above.
- National Institutes of Health Clinical Center · 2 studies
- Children's National Medical Center
- TSC Alliance
What taking part in a lymphangioleiomyomatosis study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Common questions
- Are there lymphangioleiomyomatosis clinical trials near Washington, D.C.?
- Yes. We're currently tracking 3 recruiting lymphangioleiomyomatosis studies with a site near Washington, D.C., each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a lymphangioleiomyomatosis study near Washington, D.C.?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Washington, D.C. to take part?
- Not necessarily. These studies have a site near Washington, D.C., but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a lymphangioleiomyomatosis trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New lymphangioleiomyomatosis studies open near Washington, D.C. regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.